CureVac Ownership | Who Owns CureVac?

Overview Forecast RevenueFinancials Chart Transcripts

CureVac Ownership Summary

CureVac is owned by 4.97% institutional investors, 45.26% insiders, and 49.77% retail investors. Point72 asset management is the largest institutional shareholder, holding 1.08% of CVAC shares. iShares Biotechnology ETF is the top mutual fund, with 0.29% of its assets in CureVac shares.

CVAC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	CureVac	4.97%	45.26%	49.77%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Point72 asset management	2.42M	1.08%	$8.24M
Blackrock	2.25M	1.00%	$7.66M
Bill & melinda gates foundation	1.60M	0.71%	$5.43M
Goldman sachs group	395.10K	0.18%	$1.34M
Morgan stanley	307.90K	0.14%	$1.05M
Ubs asset management americas	302.30K	0.13%	$1.03M
Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main	279.27K	0.12%	$923.21K
Geode capital management	261.23K	0.12%	$888.18K
Swiss national bank	198.55K	0.09%	$658.16K
Deutsche bank ag\	151.04K	0.07%	$513.55K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bill & melinda gates foundation	1.60M	9.09%	$5.43M
Crawford fund management	62.00K	0.05%	$210.80K
Green alpha advisors	19.34K	0.05%	$65.76K
Virtus etf advisers	22.63K	0.04%	$76.94K
Point72 asset management	2.42M	0.02%	$8.24M
Freestone capital	139.57K	0.02%	$474.55K
China universal asset management	26.35K	0.01%	$89.59K
Quinn opportunity partners	30.00K	0.01%	$102.00K
Xtx topco	31.65K	0.01%	$107.60K
Quadrant capital group	34.08K	0.01%	$115.87K

Top Buyers

Holder	Shares	% Assets	Change
Point72 asset management	2.42M	0.02%	2.42M
Ubs asset management americas	302.30K	0.00%	302.30K
Blackrock	2.25M	0.00%	278.81K
Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main	279.27K	0.00%	182.88K
Freestone capital	139.57K	0.02%	139.57K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-1.97M
Platinum investment management	-	-	-626.68K
Ubs group	112.97K	0.00%	-591.22K
Camber capital management lp	-	-	-550.00K
Morgan stanley	307.90K	0.00%	-536.32K

New Positions

Holder	Shares	% Assets	Change	Value
Point72 asset management	2.42M	0.02%	2.42M	$8.24M
Ubs asset management americas	302.30K	0.00%	302.30K	$1.03M
Freestone capital	139.57K	0.02%	139.57K	$474.55K
Legal & general group	119.01K	0.00%	119.01K	$395.13K
Millennium management	118.30K	0.00%	118.30K	$402.22K

Sold Out

Holder	Change
Cwm	-183.00
Brown brothers harriman	-355.00
Whittier trust	-585.00
Lazard asset management	-2.57K
Compagnie lombard odier scma	-3.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	82	-8.89%	11,146,865	-21.15%	4	12.51%	36	-28.00%	27	35.00%
Jun 30, 2024	90	-2.17%	14,136,665	-17.47%	6	10.77%	50	4.17%	20	-16.67%
Mar 31, 2024	92	-6.12%	17,129,874	-22.28%	7	7.90%	48	2.13%	24	-11.11%
Dec 31, 2023	98	6.52%	22,041,167	-34.34%	9	4.38%	47	2.17%	27	3.85%
Sep 30, 2023	92	-1.08%	33,566,668	-5.77%	14	5.28%	46	-6.12%	26	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Biotechnology ETF	651.42K	0.29%	-3.89K
iShares Core MSCI EAFE ETF	583.14K	0.26%	850.00
iShares MSCI EAFE Small-Cap ETF	311.04K	0.14%	-
State St Gbl Sm Cp Eq ex-US Indx NL Cl A	212.26K	0.09%	-
iShares MSCI EMU Small Cap ETF EUR Acc	181.99K	0.08%	-
Xtrackers MSCI Eur Small Cap ETF 1C	151.22K	0.07%	151.22K
iShares Genomics Immnlgy & Hlthcr ETF	145.75K	0.07%	-
Galileo - Biotech Innovation Fund S USD	131.66K	0.06%	-
iShares Nasdaq US Biotech ETF USD Acc	128.04K	0.06%	-
Fidelity Nasdaq Composite ETF	124.86K	0.06%	-128.00

CVAC Ownership FAQ

Who Owns CureVac?

CureVac shareholders are primarily institutional investors at 4.97%, followed by 45.26% insiders and 49.77% retail investors. The average institutional ownership in CureVac's industry, Biotech Stocks , is 47.04%, which CureVac falls below.

Who owns the most shares of CureVac?

CureVac’s largest shareholders are Point72 asset management (2.42M shares, 1.08%), Blackrock (2.25M shares, 1.00%), and Bill & melinda gates foundation (1.6M shares, 0.71%). Together, they hold 2.80% of CureVac’s total shares outstanding.

Does Blackrock own CureVac?

Yes, BlackRock owns 1.00% of CureVac, totaling 2.25M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.66M$. In the last quarter, BlackRock increased its holdings by 278.82K shares, a 14.12% change.

Who is CureVac’s biggest shareholder by percentage of total assets invested?

Bill & melinda gates foundation is CureVac’s biggest shareholder by percentage of total assets invested, with 9.09% of its assets in 1.6M CureVac shares, valued at 5.43M$.

Who is the top mutual fund holder of CureVac shares?

iShares Biotechnology ETF is the top mutual fund holder of CureVac shares, with 0.29% of its total shares outstanding invested in 651.42K CureVac shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools